Skip to content
AnalystLens

Natera 8-K Report, Corporate Update (Jan 22, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed January 22, 2024
Period End
January 17, 2024
Security
NTRA
In the record · 2016–202610-K1110-Q348-K105

NTRA filed 11 annual reports (10-K), 34 quarterly reports (10-Q) and 105 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Aug ’17Aug ’17
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Jul ’26Jul ’26

01—Abstract

Summary

Summary of the 8-K filed January 22, 2024. Cited figures are marked; the original filing is the authoritative source.

Natera, Inc. (NASDAQ: NTRA) filed this Current Report on Form 8-K under Item 8.01 (Other Events) to disclose that on January 22, 2024 it issued a press release announcing its acquisition of certain assets relating to Invitae Corporation's non-invasive prenatal screening and carrier screening business.

The press release is furnished as Exhibit 99.1. According to the press release, Natera made an upfront payment of $10 milliona to Invitae. The transaction also includes $42.5 million in potential milestone payments, which include cash and litigation-related credits.

Under the agreement, Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera. The filing is a brief notice of a single asset acquisition. It contains no financial results or guidance, and the press release states that Natera's forward-looking statements include risks around acquisitions, dispositions and other strategic transactions, including possible dilution to stockholders or reduced financial resources.

02—Key points

Key Highlights

  1. Natera acquired certain assets from Invitae relating to its non-invasive prenatal screening (NIPS) and carrier screening business, announced January 22, 2024.
  2. Upfront payment of $10 million to Invitae.
  3. Up to $42.5 million in potential milestone payments, including cash and litigation-related credits.
  4. Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera.
  5. CEO Steve Chapman said the company looks forward to supporting additional patients and providers.
  6. The filing is a short Item 8.01 (Other Events) notice and includes no financial statements or results.

03—Questions

Frequently Asked Questions

  1. What did Natera acquire?

    Natera acquired certain assets relating to Invitae's non-invasive prenatal screening and carrier screening business, and Invitae will transition those customers to Natera.

  2. How much is the transaction worth?

    Natera made an upfront payment of $10 million to Invitae. The transaction also includes $42.5 million in potential milestone payments, which include cash and litigation-related credits.

  3. Why does this matter for investors?

    The press release frames the deal as expanding Natera's reach to additional patients and providers. The filing notes that acquisitions could disrupt the business, cause dilution to stockholders or reduce financial resources.

  4. Does the filing include financial results or guidance?

    No. The 8-K only announces the acquisition by press release and includes a cover page interactive data file as Exhibit 104.

04—Continue

← View all 8-K filings